Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Microarrays & Multiplexing » Enzo, Hologic, Grifols Settle Patent Dispute

Enzo, Hologic, Grifols Settle Patent Dispute

Apr 22, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Enzo Life Sciences has entered into a settlement and license agreement with Hologic, Grifols, and Grifols Diagnostic Solutions, Enzo disclosed in a recent filing with the US Securities and Exchange Commission.

The agreement settles all outstanding patent disputes among the parties and includes a one-time payment of $14 million to Enzo in exchange for fully paid-up, worldwide licenses to Hologic and Grifols, according to the SEC document.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

To Get Back Going

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

UK COVID-19 Disparities Report

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

Trials Figure Out Paths Forward Despite Pandemic

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

Nature Papers Present CRISPR-Cas3 System to Make Large Genomic Deletions, Molecular Mechanisms of Chemoresistance in ALL

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.

Oct
28
Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
03
Featured Webinar

A Streamlined Targeted NGS Workflow for Comprehensive Genomic Profiling of Different Tumor Samples

Sponsored by
Agilent

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Q3 Revenues Soar 36 Percent

  2. Invitae, Pacific Biosciences Collaborate on NGS-Based Pediatric Epilepsy Testing

  3. Abbott Q3 Diagnostics Revenues Increase 38 Percent

  4. Danaher Q3 Revenues Up 35 Percent

  5. Thermo Fisher Scientific Continues to See Strong Demand for Pandemic-Related Products and Services

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.